Literature DB >> 18198208

Platelet-lymphocyte cross-talk.

Nailin Li1.   

Abstract

Platelets and lymphocytes reciprocally regulate mutual functions, i.e., platelet-lymphocyte cross-talk. The heterotypic interactions have emerged as important regulatory mechanisms in the pathophysiological processes of thrombosis, inflammation, immunity, and atherosclerosis. Platelets influence lymphocyte function via direct cell-cell contact and/or soluble mediators. Hence, platelets enhance adhesion and cell migration of T(H), T cytolytic (T(C)), NK, and B cells. Platelets affect other functional aspects of lymphocyte subpopulations in a complex manner. They may attenuate cytokine secretion and immunosuppressive responses of T(H) cells and enhance T(C) cell proliferation and cytotoxicity. Platelets promote isotype shifting and antibody production of B cells but ameliorate cytolytic activity of NK cells. On the other hand, lymphocytes can also regulate platelet aggregation and secretion, as well as the effector cell function of platelets in immune defense. The two cell types collaborate in transcellular phospholipid metabolism, CD40-CD40 ligand-mediated intercellular signaling, and their involvements in atherogenesis. The research perspectives of platelet-lymphocyte cross-talk have also been addressed.

Entities:  

Mesh:

Year:  2008        PMID: 18198208     DOI: 10.1189/jlb.0907615

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  46 in total

Review 1.  Platelets: a critical link between inflammation and microvascular dysfunction.

Authors:  Karen Y Stokes; D Neil Granger
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

2.  Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation.

Authors:  C C Lin; M Ezzelarab; R Shapiro; B Ekser; C Long; H Hara; G Echeverri; C Torres; H Watanabe; D Ayares; A Dorling; D K C Cooper
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 3.  Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum.

Authors:  Adriana Vieira-de-Abreu; Robert A Campbell; Andrew S Weyrich; Guy A Zimmerman
Journal:  Semin Immunopathol       Date:  2011-08-06       Impact factor: 9.623

Review 4.  Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases.

Authors:  C Hu; F S Wong; L Wen
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 5.  Role of blood cells in ischaemia-reperfusion induced endothelial barrier failure.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Cardiovasc Res       Date:  2010-03-17       Impact factor: 10.787

Review 6.  Influence of mental stress on platelet bioactivity.

Authors:  Pia Koudouovoh-Tripp; Barbara Sperner-Unterweger
Journal:  World J Psychiatry       Date:  2012-12-22

7.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis.

Authors:  Milka Koupenova; Olga Vitseva; Christopher R MacKay; Lea M Beaulieu; Emelia J Benjamin; Eric Mick; Evelyn A Kurt-Jones; Katya Ravid; Jane E Freedman
Journal:  Blood       Date:  2014-04-22       Impact factor: 22.113

8.  Platelets Play Differential Role During the Initiation and Progression of Autoimmune Neuroinflammation.

Authors:  Sarah C Starossom; Tatyana Veremeyko; Amanda W Y Yung; Marina Dukhinova; Cheryl Au; Alexander Y Lau; Howard L Weiner; Eugene D Ponomarev
Journal:  Circ Res       Date:  2015-08-20       Impact factor: 17.367

Review 9.  Platelets in Pulmonary Immune Responses and Inflammatory Lung Diseases.

Authors:  Elizabeth A Middleton; Andrew S Weyrich; Guy A Zimmerman
Journal:  Physiol Rev       Date:  2016-08-03       Impact factor: 37.312

10.  KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.

Authors:  A Rivero-Juarez; R Gonzalez; M Frias; B Manzanares-Martín; D Rodriguez-Cano; I Perez-Camacho; A Gordon; F Cuenca; A Camacho; J A Pineda; J Peña; A Rivero
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.